Fidelity Disruptive Medicine ETF (NASDAQ:FMED) Short Interest Up 324.2% in June

Fidelity Disruptive Medicine ETF (NASDAQ:FMED) saw a significant increase in short interest in the month of June. As of June 30th, there was short interest totaling 2,265 shares, an increase of 324.2% from the June 15th total of 534 shares. Approximately 0.1% of the shares of the company are short sold. Based on an average trading volume of 7,256 shares, the short-interest ratio is presently 0.3 days.

Hedge Funds Weigh In On Fidelity Disruptive Medicine ETF

Several hedge funds and other institutional investors have recently modified their holdings of FMED. Wealth Enhancement Advisory Services LLC increased its holdings in shares of Fidelity Disruptive Medicine ETF by 4.6% in the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 714,991 shares of the company’s stock worth $19,712,000 after acquiring an additional 31,629 shares during the period. Jane Street Group LLC grew its position in Fidelity Disruptive Medicine ETF by 95.4% in the 4th quarter. Jane Street Group LLC now owns 91,414 shares of the company’s stock worth $2,473,000 after purchasing an additional 44,630 shares during the last quarter. Vise Technologies Inc. acquired a new stake in shares of Fidelity Disruptive Medicine ETF in the fourth quarter valued at approximately $234,000. Virtu Financial LLC bought a new stake in shares of Fidelity Disruptive Medicine ETF during the fourth quarter valued at approximately $228,000. Finally, Glass Jacobson Investment Advisors llc boosted its position in shares of Fidelity Disruptive Medicine ETF by 44.0% during the fourth quarter. Glass Jacobson Investment Advisors llc now owns 1,260 shares of the company’s stock worth $34,000 after buying an additional 385 shares during the period.

Fidelity Disruptive Medicine ETF Stock Performance

Shares of Fidelity Disruptive Medicine ETF stock traded down $0.57 on Monday, reaching $28.99. 24,931 shares of the company were exchanged, compared to its average volume of 12,462. The firm has a market cap of $46.38 million, a price-to-earnings ratio of 41.33 and a beta of 0.74. Fidelity Disruptive Medicine ETF has a 1-year low of $22.80 and a 1-year high of $30.33. The company’s 50-day moving average is $26.13 and its two-hundred day moving average is $26.00.

About Fidelity Disruptive Medicine ETF

The Fidelity Disruptive Medicine ETF (FMED) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that invests in companies involved in disruptive innovation in Health Care. The fund invests in securities of domestic and foreign issuers FMED was launched on Apr 16, 2020 and is managed by Fidelity.